On March 18, Governor Kate Brown appointed members of the Oregon Celosibine Advisory Committee, which held its first meeting on March 31. Since then, the committee has held monthly meetings and established five subcommittees to study all aspects of the emerging cylosibin industry, including research, equity, manufacturing, training, and licensing. I chair the Licensing Subcommittee, which focuses on public health and safety, ethics and consumer protection. We are developing informed consent documents, professional codes of conduct and licensing requirements for psilocybin practitioners and facilities.
Each subcommittee will report its findings to the full advisory committee, which will make regulatory recommendations to OHA on or before June 30, 2022. After the end of the two-year development phase stipulated by Measure No. 109, OHA will begin accepting companies and individuals on January 2, 2023.
Measure 109 requires OHA to issue licenses for psilocybin manufacturers, testing laboratories, service centers, and promoters. In terms of manufacturing, the board of directors is considering a series of psilocybin products that can be produced in Oregon.Its product subcommittee consists of Dr. Jessie UehlingThe mycology professor at Oregon State University is studying the advantages and disadvantages of various products and manufacturing methods. The team can also resolve related issues, such as product testing, storage, and labeling.
When a manufacturer submits a license application to OHA, they must request the agency to approve at least one type of manufacturing activity. Although it is not clear which manufacturing activities will be allowed, the product subcommittee has discussed the cultivation of psilocybin-producing fungi, extraction of psilocybin from fungal materials, chemical or biosynthesis of psilocybin, and various The production of products containing psilocybin is recognized as consumption. Under Measure 109, licensed manufacturers will be allowed to add endorsements to their licenses without paying additional fees.
After the license is issued, psilocybin will only be managed by trained and licensed service personnel in the designated service center. Tom EckertHe is a licensed professional consultant and lead applicant for Measure 109, serves as the chairman of the board of directors and leads its training subcommittee, which is developing training requirements for aspiring facilitators. According to Measure 109, OHA cannot require counselors to have a high school education or equivalent. However, the training subcommittee has considered requiring some coordinators to have or obtain additional training before administering psilocybin to clients with complex medical or psychological conditions.
Dr. Rachel Knox and Dr. Angela Carter Co-chair the equity subcommittee of the board of directors to ensure that the industries created by Measure 109 are safe and accessible, especially for marginalized communities.The subcommittee includes members from outside the board of directors who have extensive experience in various disciplines, including Dr. Pilar Hernandez-Wolfe, Clinicians and professors at the Lewis and Clark Graduate School of Education and Consulting, Rebecca Martinez, And promote and educate with the fruit collective, and Ismail Ali, Acting Director of Policy and Advocacy of the Multidisciplinary Society for Psychedelic Studies (MAPS).
Members of the public are welcome to attend the meetings of the Board of Directors and its subcommittees.The schedule of upcoming events and recordings of past meetings can be found on OHA Test 109 website. Companies and individuals wishing to learn more about Oregon’s Celosíbin regulations can contact experienced Psychedelic lawyer In Harris Bricken.